These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A unified cell biological perspective on axon-myelin injury. Simons M; Misgeld T; Kerschensteiner M J Cell Biol; 2014 Aug; 206(3):335-45. PubMed ID: 25092654 [TBL] [Abstract][Full Text] [Related]
25. Aging-Exacerbated Acute Axon and Myelin Injury Is Associated with Microglia-Derived Reactive Oxygen Species and Is Alleviated by the Generic Medication Indapamide. Michaels NJ; Lemmon K; Plemel JR; Jensen SK; Mishra MK; Brown D; Rawji KS; Koch M; Yong VW J Neurosci; 2020 Oct; 40(44):8587-8600. PubMed ID: 33060175 [TBL] [Abstract][Full Text] [Related]
26. Oligodendrocytes: Functioning in a Delicate Balance Between High Metabolic Requirements and Oxidative Damage. Roth AD; Núñez MT Adv Exp Med Biol; 2016; 949():167-181. PubMed ID: 27714689 [TBL] [Abstract][Full Text] [Related]
27. An emerging role of dysfunctional axon-oligodendrocyte coupling in neurodegenerative diseases. Mot AI; Depp C; Nave KA Dialogues Clin Neurosci; 2018 Dec; 20(4):283-292. PubMed ID: 30936768 [TBL] [Abstract][Full Text] [Related]
29. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation. Madsen PM; Pinto M; Patel S; McCarthy S; Gao H; Taherian M; Karmally S; Pereira CV; Dvoriantchikova G; Ivanov D; Tanaka KF; Moraes CT; Brambilla R J Neurosci; 2017 Oct; 37(42):10185-10199. PubMed ID: 28931570 [TBL] [Abstract][Full Text] [Related]
30. Survival of oligodendrocytes in chronic relapsing experimental autoimmune encephalomyelitis. Moore GR; Traugott U; Raine CS J Neurol Sci; 1984 Aug; 65(2):137-45. PubMed ID: 6481396 [TBL] [Abstract][Full Text] [Related]
31. Ultrastructure of multiple sclerosis. Rodriguez M; Scheithauer B Ultrastruct Pathol; 1994; 18(1-2):3-13. PubMed ID: 8191643 [TBL] [Abstract][Full Text] [Related]
32. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. Lee SC; Moore GR; Golenwsky G; Raine CS J Neuropathol Exp Neurol; 1990 Mar; 49(2):122-36. PubMed ID: 2307980 [TBL] [Abstract][Full Text] [Related]
33. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Harrington EP; Zhao C; Fancy SP; Kaing S; Franklin RJ; Rowitch DH Ann Neurol; 2010 Nov; 68(5):703-16. PubMed ID: 20853437 [TBL] [Abstract][Full Text] [Related]
34. In vivo damage of CNS myelin and axons induced by peroxynitrite. Touil T; Deloire-Grassin MS; Vital C; Petry KG; Brochet B Neuroreport; 2001 Nov; 12(16):3637-44. PubMed ID: 11733726 [TBL] [Abstract][Full Text] [Related]
35. Iron Metabolism in Oligodendrocytes and Astrocytes, Implications for Myelination and Remyelination. Cheli VT; Correale J; Paez PM; Pasquini JM ASN Neuro; 2020; 12():1759091420962681. PubMed ID: 32993319 [TBL] [Abstract][Full Text] [Related]
36. Axonal loss in multiple sclerosis: causes and mechanisms. Criste G; Trapp B; Dutta R Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515 [TBL] [Abstract][Full Text] [Related]
37. Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis. Honorat JA; Kinoshita M; Okuno T; Takata K; Koda T; Tada S; Shirakura T; Fujimura H; Mochizuki H; Sakoda S; Nakatsuji Y PLoS One; 2013; 8(8):e71329. PubMed ID: 23951137 [TBL] [Abstract][Full Text] [Related]
38. Promoting myelin repair and return of function in multiple sclerosis. Zhang J; Kramer EG; Asp L; Dutta DJ; Navrazhina K; Pham T; Mariani JN; Argaw AT; Melendez-Vasquez CV; John GR FEBS Lett; 2011 Dec; 585(23):3813-20. PubMed ID: 21864535 [TBL] [Abstract][Full Text] [Related]
39. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Keirstead HS; Blakemore WF Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms of primary axonal damage in a viral model of multiple sclerosis. Das Sarma J; Kenyon LC; Hingley ST; Shindler KS J Neurosci; 2009 Aug; 29(33):10272-80. PubMed ID: 19692601 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]